SCHEMBL3417804

SCHEMBL3417804

C=C(C)C(=O)OC12CC3CC(CC(OCCCCCCC4(CCCC)CCO4)(C3)C1)C2

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DPP8 Q6V1X1 1/20 0.35
DPP9 Q86TI2 1/20 0.35
TSHR P16473 2/20 0.34
EPHX2 P34913 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3418057 1.00 DPP8 (0.35) DPP8DPP9TSHREPHX2
SCHEMBL3417150 1.00 DPP8 (0.35) DPP8DPP9TSHREPHX2
SCHEMBL3422655 0.99 DPP8 (0.35) DPP8DPP9TSHR
SCHEMBL3421649 0.96 DPP8 (0.33) DPP8DPP9TSHR
SCHEMBL3422234 0.96 DPP8 (0.33) DPP8DPP9TSHR
SCHEMBL3417688 0.96 DPP8 (0.33) DPP8DPP9TSHR
SCHEMBL3417641 0.96 DPP8 (0.36) DPP8DPP9TSHR
SCHEMBL3416461 0.94 DPP8 (0.34) DPP8DPP9TSHR
SCHEMBL3417475 0.93 DPP8 (0.32) DPP8DPP9TSHR
SCHEMBL3417805 0.93 DPP8 (0.32) DPP8DPP9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130712-A1 ADAMANTANE DERIVATIVE, RESIN COMPOSITION USING THE SAME, AND RESIN CURED PRODUCT IDEMITSU KOSAN CO., LTD. (JP) 2010-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130712-A1 ADAMANTANE DERIVATIVE, RESIN COMPOSITION USING THE SAME, AND RESIN CURED PRODUCT ARCN1, APP, ADAM17 DPP8 2365/4885DPP9 2833/4885TSHR 4737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.